InnoCare Pharma Ltd. is a clinical-stage biopharmaceutical company. It engages in discovering, developing and commercializing drugs for the treatment of cancer and autoimmune diseases. The company was founded by Jisong Cui and Yigong Shi on November 3, 2015 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company